1. Archer GL, Climo MW. Staphylococcus aureus bacteremia--consider the source. N Engl J Med 2001; 344(1): 55-6.
2. Kaplan SL, Hulten KG, Gonzalez BE, Hammerman WA, Lamberth L, Versalovic J, et al. Three-year surveillance of
community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40(12): 1785-91.
3. Shajari GR, Moniri R. Pattern of Staphylococcous aureus susceptibility and resistance to antibiotics in Kashan. J Kashan Univ Med Sic (Feyz) 2002; 6(3): 31-6. [In Persian].
4. Perumal P, Mekala S, Chaffin WL. Role for Cell Density in Antifungal Drug Resistance in Candida albicans Biofilms. Antimicrob Agents Chemother 2007; 51(7): 2454-63.
5. Seneviratne CJ, Jin LJ, Samaranayake YH, Samaranayake LP. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms. Antimicrob Agents Chemother 2008; 52(9): 3259-66.
6. Al-Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 2006; 55(Pt 8): 999-1008.
7. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991; 4(1): 80-128.
8. Lemonnier M, Landraud L, Lemichez E. Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol Rev 2007; 31(5): 515-34.
9. Davis JM, Carvalho HM, Rasmussen SB, O’Brien AD. Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis. Infect Immun 2006; 74(8): 4401-8.
10. Norouzi J, Vali GR, Yousefi H. Surveying the effects of different methods of motations on the antibiotic resistance patterns and plasmids in E. coli and S. aureus. J Kashan Univ Med Sic (Feys) 2004; 8(1): 1-8. [In Persian].
11. Makovee JA, Ruegg PL. Antimicrobial resistance of bacteria isolated from dairy cow milk samples submitted for bacterial culture: 8,905 samples (1994-2001). J Am Vet Med Assoc 2003; 222(11): 1582-9.
12. James TK, Rahman A. Chemical control of field horsetail (Equisetum arvense). Biology and Control of Weeds 2010; 63: 102-7.
13. Beckert C, Horn C, Schnitzler JP, Lehning A, Heller W, Veit M. Styrylpyrone biosynthesis in Equisetum arvense. Phytochemistry 1997; 44(2): 275-83.
14. Čanadanović-Brunet JM, Ćetković GS, Djilas SM, Tumbas VT, Savatović SS, Mandić AI, et al. Radical scavenging and antimicrobial activity of horsetail (Equisetum arvense L.) extracts. Int J Food Sci Technol 2009; 44(2): 269-78.
15. Radulovi N, Stojanović G, Palić R. Composition and Antimicrobial Activity of Equisetum arvense L. Essential Oil. Phytother Res 2006; 20(1): 85-8.
16. Emin Uslu M, Erdogan I, Bayraktar O, Ates M. Optimization of extraction conditions for active components in Equisetum arvense extract. Romanian Biotechnological Letters 2013; 18(2): 8115-31.
17. Vesna M, Niko R, Zoran T. Miroslavast, gordanast, antioxidant, antimicrobial and genotoxicity screening of hydro-alcoholic extracts of five Serbian Equisetum species. Plant Foods Hum Nutr 2007;62:113-9.
18. Stajner D, Popović BM, Canadanović-Brunet J, Anackov G. Exploring Equisetum arvense L., Equisetum ramosissimum L. and Equisetum telmateia L. as sources of natural antioxidants. Phytother Res 2009; 23(4): 546-50.
19. Mimica-Dukic N, Simin N, Cvejic J, Jovin E, Orcic D, Bozin B. Phenolic compounds in field horsetail (Equisetum arvense L.) as natural antioxidants. Molecules 2008; 13(7): 1455-64.
20. Fathi Azad F, Lotfipour F. Study on the invitro antimicrobial activity of Achillea millefolium and Equisetum arvense. Pharm Sci 2004; 1: 37-46.